Skip to main
AHR

AHR Stock Forecast & Price Target

AHR Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 25%
Buy 67%
Hold 8%
Sell 0%
Strong Sell 0%

Bulls say

American Healthcare REIT Inc. has demonstrated significant financial strength, with rental rate growth of 4.1% year-over-year and robust same-store Net Operating Income (NOI) growth, notably 25.3% for SHOP and 21.7% for Integrated Senior Health Campuses (ISHC). The company is experiencing the highest Funds From Operations (FFO) growth rate within the Healthcare REIT sector, supported by favorable industry dynamics and operational efficiencies. Additionally, with a superior cost of capital enabling proactive investment strategies, American Healthcare REIT is expected to achieve continued strong organic growth, particularly in its Trilogy and SHOP segments, which are projected to generate two-year Compound Annual Growth Rates (CAGR) of 11.8% and 15.5%, respectively.

Bears say

American Healthcare REIT Inc. has demonstrated some improvements in its leverage metrics, with net debt to GAV decreasing to 28.8% as of 2Q25 from 38.7% in 3Q2024, indicating a strengthening balance sheet. However, the reliance on integrated senior health campuses for revenue, coupled with potential economic headwinds and regulatory changes in certain geographies, raises concerns regarding the operating performance of tenants, which could adversely affect earnings expectations. Furthermore, the lower initial yields on investments, despite promising growth prospects, suggest a challenging environment that may hinder the overall financial stability of the REIT.

AHR has been analyzed by 12 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 67% recommend Buy, 8% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of American Healthcare REIT Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About American Healthcare REIT Inc (AHR) Forecast

Analysts have given AHR a Buy based on their latest research and market trends.

According to 12 analysts, AHR has a Buy consensus rating as of Jan 10, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $50.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $50.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

American Healthcare REIT Inc (AHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.